Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.
J Biol Chem
; 292(10): 4359, 2017 03 10.
Article
in En
| MEDLINE
| ID: mdl-28283588
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Biol Chem
Year:
2017
Document type:
Article